Literature DB >> 10944592

Advanced-stage cervix cancer: rapid tumour growth rather than late diagnosis.

P Symonds1, B Bolger, D Hole, J H Mao, T Cooke.   

Abstract

Either diagnostic delay or tumour biology are possible factors governing the degree of spread at diagnosis of cervical cancer. To try to identify the most important parameter contributing to advanced stage, the duration of symptoms were recorded from patients scheduled for radiotherapy (n = 141) or radical hysterectomy (n = 36). In 146 cases tumour proliferation rates were evaluated following in vivo labelling with the DNA precursor BrdUrd. For symptomatic patients there was no association between duration of symptoms and stage at presentation. There was a significant trend for patients with increasing tumour stage to have more rapidly proliferating tumours with higher mean labelling index (LI) measurements (P = 0.001) and a shorter mean potential doubling time (Tpot) (P = 0.023). Socio economic deprivation may be associated with shorter Tpot values. The conclusion from this data is that stage at diagnosis is more dependent on the biological behaviour of the tumour, as expressed by proliferation rates, than delay in presentation. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944592      PMCID: PMC2363515          DOI: 10.1054/bjoc.2000.1336

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.

Authors:  R W Tsang; C S Wong; A W Fyles; W Levin; L A Manchul; M Milosevic; W Chapman; Y Q Li; M Pintilie
Journal:  Radiother Oncol       Date:  1999-01       Impact factor: 6.280

2.  Clinical characteristics and diagnostic delay of head and neck cancer: results from a prospective study in Belgium.

Authors:  I J Dhooge; F W Albers; P B van Cauwenberge
Journal:  Eur J Surg Oncol       Date:  1996-08       Impact factor: 4.424

3.  Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions.

Authors:  P R Palan; C J Chang; M S Mikhail; G Y Ho; J Basu; S L Romney
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

Review 4.  Human cervical cancer. Retinoids, interferon and human papillomavirus.

Authors:  R L Eckert; C Agarwal; J R Hembree; C K Choo; N Sizemore; S Andreatta-van Leyen; E A Rorke
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

5.  Human papillomavirus genotype as a major determinant of the course of cervical cancer.

Authors:  I Lombard; A Vincent-Salomon; P Validire; B Zafrani; A de la Rochefordière; K Clough; M Favre; P Pouillart; X Sastre-Garau
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

6.  Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.

Authors:  G D Wilson; S Dische; M I Saunders
Journal:  Radiother Oncol       Date:  1995-09       Impact factor: 6.280

7.  Age, substance abuse, and survival of patients with cervical carcinoma.

Authors:  E Serur; R G Fruchter; M Maiman; J McGuire; C D Arrastia; D Gibbon
Journal:  Cancer       Date:  1995-05-15       Impact factor: 6.860

8.  Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate.

Authors:  B S Bolger; R P Symonds; P D Stanton; A B MacLean; R Burnett; P Kelly; T G Cooke
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

9.  Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.

Authors:  B S Bolger; T G Cooke; R P Symonds; A B MacLean; P D Stanton
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

10.  Age, socio-economic status and survival from cancer of cervix in the West of Scotland 1980-87.

Authors:  D W Lamont; R P Symonds; M M Brodie; N J Nwabineli; C R Gillis
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more
  12 in total

1.  Cancer biology may be more important than diagnostic delay.

Authors:  R Paul Symonds
Journal:  BMJ       Date:  2002-10-05

2.  Prognostic implications of emergency admission and delays in patients with breast cancer.

Authors:  Maximino Redondo; Isabel Rodrigo; Teresa Pereda; Rafael Funez; Mercedes Acebal; Emilio Perea-Milla; Eugenio Jimenez
Journal:  Support Care Cancer       Date:  2008-10-08       Impact factor: 3.603

3.  Optimal MRI interval for detection of asymptomatic recurrence in surgically treated early cervical cancer by use of a mathematical model.

Authors:  A Laios; K Gubbala; R Lampe; A Tolis
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

4.  Onset time of tumor repopulation for cervical cancer: first evidence from clinical data.

Authors:  Zhibin Huang; Nina A Mayr; Mingcheng Gao; Simon S Lo; Jian Z Wang; Guang Jia; William T C Yuh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-02       Impact factor: 7.038

5.  Predicting outcomes in cervical cancer: a kinetic model of tumor regression during radiation therapy.

Authors:  Zhibin Huang; Nina A Mayr; William T C Yuh; Simon S Lo; Joseph F Montebello; John C Grecula; Lanchun Lu; Kaile Li; Hualin Zhang; Nilendu Gupta; Jian Z Wang
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

6.  Diagnostic Pathway of Oral Cavity Cancer in an Integrated Health Care System.

Authors:  Kevin H Wang; Brian H Song; Jason E Gilde; Jeanne A Darbinian; Miranda L Ritterman Weintraub; Tara J Wu; Eleanor L Yang; James W Salazar; Deepak Gurushanthaiah
Journal:  Perm J       Date:  2018

7.  Are alarm symptoms predictive of cancer survival?: population-based cohort study.

Authors:  Alex Dregan; Henrik Møller; Judith Charlton; Martin C Gulliford
Journal:  Br J Gen Pract       Date:  2013-12       Impact factor: 5.386

8.  Factors that influence treatment delay in patients with colorectal cancer.

Authors:  Irene Zarcos-Pedrinaci; Alberto Fernández-López; Teresa Téllez; Francisco Rivas-Ruiz; Antonio Rueda; María Manuela Morales Suarez-Varela; Eduardo Briones; Marisa Baré; Antonio Escobar; Cristina Sarasqueta; Nerea Fernández de Larrea; Urko Aguirre; José María Quintana; Maximino Redondo
Journal:  Oncotarget       Date:  2017-05-30

9.  Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival.

Authors:  M Pitchers; C Martin
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

10.  Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study.

Authors:  Priscilla Dunyo; Kofi Effah; Emilia Asuquo Udofia
Journal:  BMC Public Health       Date:  2018-10-03       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.